Clovis Luzivika Nzinga
8PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 16, 2023
Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort).Patrizia Carrieri, Marc Bourlière, Vincent Di Beo
|Mar 09, 2023
Dynamic personalized prediction of the individual liver-related risk after sustained viral response in HCV patients.Clémence Moreau, Marine Roux, Jérémie Riou
|Dec 18, 2022
Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the ANRS CO22 HEPATHER cohort.Laurent Lam, Hélène Fontaine, Nathanael Lapidus
|Nov 29, 2022
Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers.Laurent Lam, Hélène Fontaine, Nathanael Lapidus
|May 22, 2020
Sofosbuvir-Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real-life experience from the HEPATHER ANRS CO22 cohort.Victor de Lédinghen, Clovis Lusivika-Nzinga, Jean-Pierre Bronowicki
|Aug 07, 2019
The dynamic effect of direct-acting antiviral treatments on the risk of hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis C.Clovis Lusivika-Nzinga, Hélène Fontaine, Céline Dorival
Pageof 2
Frequent Collaborators
2 joint publications
Stanislas Pol
2 joint publications
Laurent Lam
1 joint publications
Victor de Lédinghen
1 joint publications
Fabien Zoulim
1 joint publications
Patrizia Carrieri
1 joint publications
Vincent Di Beo
1 joint publications
Clémence Ramier
1 joint publications
Camelia Protopopescu
1 joint publications
Hélène Fontaine
1 joint publications
Abbas Mourad
